Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04505839 |
Title | First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | ST Pharm Co., Ltd. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |